BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18501350)

  • 1. The L-amino acid carrier inhibitor 2-aminobicyclo[2.2.1]heptane-2-carboxylic acid (BCH) reduces L-dopa-elicited responses in dopaminergic neurons of the substantia nigra pars compacta.
    Sebastianelli L; Ledonne A; Marrone MC; Bernardi G; Mercuri NB
    Exp Neurol; 2008 Jul; 212(1):230-3. PubMed ID: 18501350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
    Biggs CS; Fisher A; Starr MS
    Synapse; 1998 Nov; 30(3):309-17. PubMed ID: 9776134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological characterization of substantia nigra dopaminergic neurons in partially lesioned rats: effects of subthalamotomy and levodopa treatment.
    Bilbao G; Ruiz-Ortega JA; Miguens N; Ulibarri I; Linazasoro G; Gómez-Urquijo S; Garibi J; Ugedo L
    Brain Res; 2006 Apr; 1084(1):175-84. PubMed ID: 16574080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
    Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
    Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual effects of L-DOPA on nigral dopaminergic neurons.
    Guatteo E; Yee A; McKearney J; Cucchiaroni ML; Armogida M; Berretta N; Mercuri NB; Lipski J
    Exp Neurol; 2013 Sep; 247():582-94. PubMed ID: 23481547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
    Mela F; Marti M; Dekundy A; Danysz W; Morari M; Cenci MA
    J Neurochem; 2007 Apr; 101(2):483-97. PubMed ID: 17359492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY; Park HJ; Ahn YH; Lee PH
    J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine.
    Meissner W; Ravenscroft P; Reese R; Harnack D; Morgenstern R; Kupsch A; Klitgaard H; Bioulac B; Gross CE; Bezard E; Boraud T
    Neurobiol Dis; 2006 Jun; 22(3):586-98. PubMed ID: 16531050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine inhibits ATP-dependent K+ conductances in dopamine neurons of the rat substantia nigra pars compacta.
    Giustizieri M; Cucchiaroni ML; Guatteo E; Bernardi G; Mercuri NB; Berretta N
    J Pharmacol Exp Ther; 2007 Aug; 322(2):721-9. PubMed ID: 17496164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subchronic administration of L-DOPA to adult rats with a unilateral 6-hydroxydopamine lesion of dopamine neurons results in a sensitization of enhanced GABA release in the substantia nigra, pars reticulata.
    Yamamoto N; Pierce RC; Soghomonian JJ
    Brain Res; 2006 Dec; 1123(1):196-200. PubMed ID: 17027936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Na+-independent transporters, LAT-2 and b0,+, exchange L-DOPA with neutral and basic amino acids in two clonal renal cell lines.
    Gomes P; Soares-da-Silva P
    J Membr Biol; 2002 Mar; 186(2):63-80. PubMed ID: 11944084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamidophos transiently inhibits neuronal nicotinic receptors of rat substantia nigra dopaminergic neurons via open channel block.
    Di Angelantonio S; Bernardi G; Mercuri NB
    Neurosci Lett; 2004 Oct; 369(3):208-13. PubMed ID: 15464266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of methylphenidate on dopaminergic neurons of the ventral midbrain.
    Federici M; Geracitano R; Bernardi G; Mercuri NB
    Biol Psychiatry; 2005 Feb; 57(4):361-5. PubMed ID: 15705351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine synthesis by non-dopaminergic neurons expressing individual complementary enzymes of the dopamine synthetic pathway in the arcuate nucleus of fetal rats.
    Ugrumov MV; Melnikova VI; Lavrentyeva AV; Kudrin VS; Rayevsky KS
    Neuroscience; 2004; 124(3):629-35. PubMed ID: 14980733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of barbiturates on ATP-sensitive K channels in rat substantia nigra.
    Ohtsuka T; Ishiwa D; Kamiya Y; Itoh H; Nagata I; Saito Y; Yamada Y; Sumitomo M; Andoh T
    Neuroscience; 2006; 137(2):573-81. PubMed ID: 16289884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of scoparone on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells.
    Yang YJ; Lee HJ; Huang HS; Lee BK; Choi HS; Lim SC; Lee CK; Lee MK
    J Neurosci Res; 2009 Jun; 87(8):1929-37. PubMed ID: 19185027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
    Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T
    Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
    Carlsson T; Carta M; Muñoz A; Mattsson B; Winkler C; Kirik D; Björklund A
    Brain; 2009 Feb; 132(Pt 2):319-35. PubMed ID: 19039008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional activity of a large neutral amino acid transporter (LAT) in rabbit retina: a study involving the in vivo retinal uptake and vitreal pharmacokinetics of L-phenyl alanine.
    Atluri H; Talluri RS; Mitra AK
    Int J Pharm; 2008 Jan; 347(1-2):23-30. PubMed ID: 17686592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.